lu 135252 has been researched along with Alloxan Diabetes in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amann, K; El-Shakmak, A; Gross, ML; Koch, A; Kuhlmann, A; Münter, K; Ritz, E; Szábó, A | 1 |
| Amann, K; Gross, ML; Helmke, B; Münter, K; Parkman, A; Ritz, E; Schoof, A; Tulp, O | 1 |
| Amann, K; El-Shakmak, A; Gross, ML; Hansen, A; Heiss, N; Münter, K; Ritz, E; Szabo, A; Weckbach, M | 1 |
| Hocher, B; Lun, A; Neumayer, HH; Priem, F; Raschack, M | 1 |
| Aus Dem Spring, C; Bollig, K; Dhein, S; Hochreuther, S; Hufnagel, C; Raschack, M | 1 |
| Bauer, C; Hocher, B; Jacobi, J; Lun, A; Neumayer, HH; Priem, F; Raschack, M; Reinbacher, D; Schwarz, A | 1 |
6 other study(ies) available for lu 135252 and Alloxan Diabetes
| Article | Year |
|---|---|
ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Endothelin Receptor Antagonists; Hypertrophy; Kidney Glomerulus; Kidney Tubules; Male; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley | 2003 |
Renal damage in the SHR/N-cp type 2 diabetes model: comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blocker.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Immunohistochemistry; Indoles; Kidney; Male; Phenylpropionates; Proliferating Cell Nuclear Antigen; Pyrimidines; Rats; RNA, Messenger; Transforming Growth Factor beta | 2003 |
ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetes.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arterioles; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular Diseases; Collagen Type IV; Coronary Vessels; Diabetes Mellitus, Experimental; Endothelin A Receptor Antagonists; Endothelin-1; Fibrosis; Gene Expression; Heart; Immunohistochemistry; In Situ Hybridization; Indoles; Male; Myocardium; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Transforming Growth Factor beta | 2004 |
Renal endothelin system in diabetes: comparison of angiotensin-converting enzyme inhibition and endothelin-A antagonism.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Kidney; Kidney Function Tests; Mice; Phenylpropionates; Proteinuria; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A | 1998 |
Long-term effects of the endothelin(A) receptor antagonist LU 135252 and the angiotensin-converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic type I diabetes mellitus rat model.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Blood Vessels; Body Weight; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathies; Endothelin Receptor Antagonists; Endothelium, Vascular; Erythrocytes; Heart Rate; Indoles; Kidney Function Tests; Male; Muscle, Smooth, Vascular; Myocardium; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A | 2000 |
Effects of endothelin receptor antagonists on the progression of diabetic nephropathy.
Topics: Animals; Collagen; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelin Receptor Antagonists; Fibronectins; Kidney Glomerulus; Laminin; Phenylpropionates; Propionates; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B | 2001 |